Our brain and nervous system control all the essential functions of life: movement, breathing, senses and thought. We are committed to improving these vital systems through innovative research, compassionate care and cutting edge therapies.
Caregivers of patients with primary malignant brain tumours can experience heightened anxiety and other psychosocial distress while providing care. This study is testing an evidence-based, telehealth psychological intervention (NeuroCARE) to improve caregivers’ quality of life by reducing their anxiety symptoms.
The non-blinded, randomised controlled trial will enrol 120 caregivers of patients with primary malignant brain tumours who screen positive for heightened anxiety. Participants will be randomly allocated to either the NeuroCARE intervention or a usual care control condition. Caregivers in the NeuroCARE group will receive six individual telehealth sessions with a trained behaviour health specialist over a 12-week period and complete study assessments at baseline, 11 weeks and 16 weeks postrandomisation. Caregivers in the usual care control group will access existing support services within their cancer centre and may be referred to social work as needed. You can also head over to Universal Neurological Care for more of this service.
Medically complicated cases require specialized expertise for fair and objective evaluation. With over 30 years of extensive IME and expert witness experience in both plaintiff and defense matters, Dr. David Hauge brings a unique perspective to the complex and delicate world of neurological medicine. From expert analysis of causation of injuries to worker’s compensation and liability, he has the ability to translate complex medical information for layman audiences. He is available to provide a full range of expert testimony in deposition and at trial.
Get your consultation at:
Universal Neurological Care, P.A.
8823 San Jose Blvd Ste. 209, Jacksonville, FL 32217
(904) 404-7044